Understanding how cells know when to grow and when to stop is one of the central questions in cancer biology and tissue homeostasis research. A newly identified molecular bridge between cellular polarity machinery and two of the most potent growth-regulating pathways in the body could reframe how scientists think about tumor suppression and tissue repair — with implications that extend well beyond basic cell biology.
Published in PNAS, this study identifies Homer proteins as critical intermediaries between the Crumbs polarity complex and downstream transcriptional programs governed by YAP and Wnt signaling. Homer proteins, previously best known for their scaffolding roles at neuronal synapses, are shown here to form biomolecular condensates — dynamic, membrane-less compartments that concentrate signaling molecules — that physically coordinate crosstalk between the YAP pathway, which senses mechanical and tissue-density cues, and the Wnt pathway, which governs cell fate and proliferation. The Crumbs complex, a conserved determinant of epithelial apical-basal polarity, appears to act upstream, recruiting Homer condensates as functional hubs that modulate transcriptional output from both pathways simultaneously.
This finding is notable for several reasons that extend beyond its mechanistic novelty. YAP and Wnt signaling are individually well-established drivers of cancer when dysregulated, and each has been pursued as a therapeutic target, so far with limited clinical success partly due to incomplete pathway understanding. The discovery that these two pathways are coordinately regulated through a shared condensate scaffold introduces condensate dissolution or stabilization as a potential therapeutic concept. The Homer-condensate mechanism also adds to growing evidence that phase separation — the physical process driving condensate formation — is not merely a structural curiosity but a central regulatory logic in signal transduction. A key limitation is that the current evidence remains largely mechanistic and likely cell-line or model-organism based, leaving open questions about how this circuitry operates in human tissues, aging epithelia, or early-stage tumors.